The bacteriology of pouchitis: A molecular phylogenetic analysis using 16s rRNA gene cloning and sequencing

Annals of Surgery

Volumn 252, Issue 1, 2010, Pages 90-98

  McLaughlin, Simon D ^a,b,c   Walker, Alan W ^d   Churcher, Carol ^d   Clark, Susan K ^b   Tekkis, Paris P ^a,b   Johnson, Matthew W ^b,c   Parkhill, Julian ^d   Ciclitira, Paul J ^c   Dougan, Gordon ^d   Nicholls, Ralph John ^a   Petrovska, Liljana ^c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ACTINOBACTERIA; ADENOMATOUS POLYP; ADOLESCENT; ADULT; ARTICLE; BACTERIAL FLORA; BACTERIOLOGY; BACTERIUM IDENTIFICATION; BACTEROIDETES; FAMILIAL POLYPOSIS; FEMALE; FIRMICUTES; GENE SEQUENCE; HUMAN; HUMAN TISSUE; ILEITIS; INTESTINE FLORA; MALE; MOLECULAR CLONING; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOBACTERIA; RNA GENE; SEQUENCE ANALYSIS; ULCERATIVE COLITIS; UNINDEXED SEQUENCE;

ADENOMATOUS POLYPOSIS COLI; ADULT; BACTEROIDETES; BASE SEQUENCE; BIOPSY; CLONING, MOLECULAR; COLITIS, ULCERATIVE; COLONIC POUCHES; DNA, BACTERIAL; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; PROTEOBACTERIA; RNA, RIBOSOMAL, 16S;

EID: 77954084505     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181e3dc8b     Document Type: Article

References (52)

1. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroen-terology. 2008;134:577-594.
2. Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol. 2000;95(suppl 1):S19-S21.
3. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs. 2003;63: 453-461.
4. McLaughlin SD, Clark SK, Bell AJ, et al. An open study of antibiotics for the treatment of pre-pouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther. In press.
5. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305-309.
6. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53:108-114.
7. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202-1209.
8. Bell AJ, Nicholls RJ, Forbes A, et al. Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut. 2004;53:1801-1805.
9. Lim M, Sagar P, Finan P, et al. Dysbiosis and pouchitis. Br J Surg. 2006;93:1325-1334.
10. Zoetendal EG, Rajilic-Stojanovic M, De Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008; 57:1605-1615.
11. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115-1118.
12. Gophna U, Sommerfeld K, Gophna S, et al. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcer-ative colitis. J Clin Microbiol. 2006;44:4136-4141.
13. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-211.
14. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, et al. Abnormal micro-biota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophore-sis. Inflamm Bowel Dis. 2006;12:1136-1145.
15. Swidsinski A, Weber J, Loening-Baucke V, et al. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005;43:3380-3389.
16. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003;52:237-242.
17. Johnson MW, Rogers GB, Bruce KD, et al. Bacterial community diversity in cultures derived from healthy and inflamed ileal pouches after restorative proctocolectomy. Inflamm Bowel Dis. 2009;15:1803-1811.
18. Bibiloni R, Mangold M, Madsen KL, et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol. 2006;55:1141-1149.
19. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.
20. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002;37:1034-1041.
21. Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 2007;1:403-418.
22. Frank DN, St. Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780-13785.
23. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421.
24. Komanduri S, Gillevet PM, Sikaroodi M, et al. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastro-enterol Hepatol. 2007;5:352-360.
25. Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Micro-biol. 1998;64:3854-3859.
26. Eckburg PB, Relman DA. The role of microbes in Crohn's disease. Clin Infect Dis. 2007;44:256-262.
27. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069-5072.
28. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc. 1994;69: 409-415.
29. Stecher B, Robbiani R, Walker AW, et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007;5:2177-2189.
30. Ludwig W, Strunk O, Westram R, et al. ARB: a software environment for sequence data. Nucleic Acids Res. 2004;32:1363-1371.
31. Ashelford KE, Chuzhanova NA, Fry JC, et al. New screening software shows that most recent large 16S rRNA gene clone libraries contain chimeras. Appl Environ Microbiol. 2006;72:5734-5741.
32. Ashelford KE, Chuzhanova NA, Fry JC, et al. At least 1 in 20 16S rRNA sequence records currently held in public repositories is estimated to contain substantial anomalies. Appl Environ Microbiol. 2005;71:7724-7736.
33. Wang Q, Garrity GM, Tiedje JM, et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261-5267.
34. Schloss PD, Handelsman J. Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl Environ Microbiol. 2005;71:1501-1506.
35. Johnson M, Zaretskaya I, Raytselis Y, et al. NCBI BLAST: a better web interface. Nucleic Acids Res. 2008;36(web server issue):W5-W9.
36. Shen B, Lashner BA. Pouchitis: a spectrum of diseases. Curr Gastroenterol Rep. 2005;7:404-411.
37. McLaughlin SD, Clark SK, Tekkis PP, et al. Review article: restorative proctocolectomy, indications, management of complications and follow-up: a guide for gastroenterologists. Aliment Pharmacol Ther. 2008;27:895-909.
38. Zoetendal EG, von Wright A, Vilpponen-Salmela T, et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002;68:3401-3407.
39. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-1638.
40. Romanos J, Samarasekera DN, Stebbing JF, et al. Outcome of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience. Br J Surg. 1997;84:814-818.
41. Stahlberg D, Gullberg K, Liljeqvist L, et al. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996;39:1012-1018.
42. Salemans JM, Nagengast FM, Lubbers EJ, et al. Postoperative and long-term results of ileal pouch-anal anastomosis for ulcerative colitis and familial polyposis coli. Dig Dis Sci. 1992;37:1882-1889.
43. Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131:497-500.
44. Lovegrove RE, Tilney HS, Heriot AG, et al. A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adeno-matous polyposis and ulcerative colitis. Dis Colon Rectum. 2006;49:1293-1306.
45. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immu-nobiology. Lancet. 2007;369:1627-1640.
46. Kuhbacher T, Ott SJ, Helwig U, et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut. 2006;55:833-841.
47. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685-693.
48. Andoh A, Sakata S, Koizumi Y, et al. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis. 2007;13:955-962.
49. Sokol H, Lepage P, Seksik P, et al. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol. 2006;44:3172-3177.
50. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731-16736.
51. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnit-zii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183-1189.
52. McLaughlin SD, Clark SK, Shafi S, et al. Fecal coliform testing to identify effective antibiotic therapies for patients with antibiotic-resistant pouchitis. Clin Gastroenterol Hepatol. 2009;7:545-548.